#EHA2025.
#outsmartingcancer
@oncodeinstitute.bsky.social
#outsmartingcancer
@oncodeinstitute.bsky.social
key point: 2/3rds of TF isos differ in properties like DNA binding & transcriptional activity
many are "negative regulators" & misexpressed in cancer
www.sciencedirect.com/science/arti...
@dpastoors.bsky.social gave nice talk on p300&CBP regulating enhancer activity in AML which was awarded with the Best Presentation Award! 🤩🥳
#Hemesky
Publications from 2025 are shared more on Bluesky than on X/Twitter.
Publications from 2025 are shared more on Bluesky than on X/Twitter.
modelarchive.org
modelarchive.org
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
rdcu.be/d8xLv (1/6)